KCS Wealth Advisory’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $760K | Buy |
22,900
+10,469
| +84% | +$347K | 0.32% | 75 |
|
|
2023
Q2 | $456K | Sell |
12,431
-252
| -2% | -$9.24K | 0.16% | 105 |
|
|
2023
Q1 | $517K | Sell |
12,683
-4,034
| -24% | -$165K | 0.2% | 96 |
|
|
2022
Q4 | $857K | Buy |
16,717
+4,341
| +35% | +$222K | 0.36% | 75 |
|
|
2022
Q3 | $542K | Sell |
12,376
-104
| -0.8% | -$4.56K | 0.25% | 97 |
|
|
2022
Q2 | $654K | Sell |
12,480
-550
| -4% | -$28.8K | 0.29% | 93 |
|
|
2022
Q1 | $675K | Sell |
13,030
-517
| -4% | -$26.8K | 0.31% | 92 |
|
|
2021
Q4 | $800K | Buy |
13,547
+862
| +7% | +$50.9K | 0.32% | 90 |
|
|
2021
Q3 | $546K | Sell |
12,685
-98
| -0.8% | -$4.22K | 0.26% | 94 |
|
|
2021
Q2 | $501K | Buy |
12,783
+500
| +4% | +$19.6K | 0.24% | 98 |
|
|
2021
Q1 | $445K | Sell |
12,283
-52
| -0.4% | -$1.88K | 0.23% | 107 |
|
|
2020
Q4 | $454K | Buy |
+12,335
| New | +$454K | 0.3% | 100 |
|
|
2019
Q4 | – | Sell |
-3,766
| Closed | -$128K | – | 334 |
|
|
2019
Q3 | $128K | Buy |
+3,766
| New | +$128K | 0.09% | 178 |
|